# Shilpa Medicare (NSE: SHILPAMED) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/SHILPAMED · Pivot · prices to 22 Oct 2026

Shilpa Medicare (NSE: SHILPAMED) closed at ₹880.90 on 22 Oct 2026, up 4.74% on the day. With a market capitalisation of ₹17,229 Cr, it ranks 382nd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

At its last close the stock traded at 70.9× trailing earnings, against a return on equity of 9.4% in FY26. Over the past year the share price has risen 150.3%. Its 52-week range is ₹259.50 (27 Jan 2026) to ₹1,095.00 (1 Oct 2026); the last close is 19.6% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹466 Cr (+44.9% year on year) and net profit ₹95 Cr (+99.3%), on a consolidated basis. Promoters held 40.13% of the company as of 30 Jun 2026; 8.73% of promoter shares were pledged.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹880.90 |
| Market cap | ₹17,229 Cr |
| P/E (trailing) | 70.9 |
| ROE | 9.4% (FY26) |
| ROCE | 11.4% (FY26) |
| Debt to equity | 0.25 |
| 52-week high | ₹1,095.00 (1 Oct 2026) |
| 52-week low | ₹259.50 (27 Jan 2026) |
| 1-year return | +150.3% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹466 Cr | +44.9% | ₹95 Cr | +99.3% | ₹5.16 |
| Q4 FY26 | ₹437 Cr | +32.1% | ₹89 Cr | +632.8% | ₹5.51 |
| Q3 FY26 | ₹410 Cr | +28.3% | ₹45 Cr | +42.9% | ₹2.36 |
| Q2 FY26 | ₹370 Cr | +7.6% | ₹44 Cr | +141.0% | ₹2.25 |
| Q1 FY26 | ₹321 Cr | +9.9% | ₹48 Cr | +170.9% | ₹4.79 |
| Q4 FY25 | ₹331 Cr | +13.4% | ₹12 Cr | −50.4% | ₹1.48 |
| Q3 FY25 | ₹319 Cr | +11.5% | ₹31 Cr | +444.9% | ₹3.25 |
| Q2 FY25 | ₹344 Cr | +9.8% | ₹18 Cr | +426.7% | ₹1.83 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹1,286 Cr | ₹80 Cr |
| FY24 | ₹1,152 Cr | ₹37 Cr |
| FY23 | ₹1,050 Cr | −₹27 Cr |
| FY22 | ₹1,146 Cr | ₹64 Cr |
| FY21 | ₹901 Cr | ₹148 Cr |
| FY20 | ₹908 Cr | ₹155 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 40.13%
- Foreign institutions: 11.38%
- Domestic institutions: 8.05%
- Non-institutions: 40.43%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Indraprastha](https://app.pivotnow.in/stock/IGL) | ₹141.87 | ₹19,862 Cr | 12.8 | — |
| [Cohance Lifesciences](https://app.pivotnow.in/stock/COHANCE) | ₹460.30 | ₹17,610 Cr | 98.6 | — |
| [Pfizer](https://app.pivotnow.in/stock/PFIZER) | ₹3,712.10 | ₹16,982 Cr | 23.5 | — |
| [Caplin Point Laboratories](https://app.pivotnow.in/stock/CAPLIPOINT) | ₹2,227.80 | ₹16,934 Cr | — | — |
| [Eris Lifesciences](https://app.pivotnow.in/stock/ERIS) | ₹1,143.60 | ₹15,848 Cr | 25.3 | — |
| [Onesource Specialty Pharma](https://app.pivotnow.in/stock/ONESOURCE) | ₹1,378.00 | ₹15,798 Cr | — | — |

## Questions and answers

### What is the share price of Shilpa Medicare today?

Shilpa Medicare (NSE: SHILPAMED) last closed at ₹880.90 on 22 Oct 2026. Its 52-week high is ₹1,095.00 and its 52-week low is ₹259.50.

### What is the market cap of Shilpa Medicare?

Shilpa Medicare's market capitalisation is ₹17,229 Cr (₹17,229 Cr) at the 22 Oct 2026 close, ranking 382nd among the NSE companies Pivot tracks.

### What is the P/E ratio of Shilpa Medicare?

Shilpa Medicare trades at a trailing P/E of 70.9. The median P/E of the 4 closest Pharma & Healthcare peers by market cap is 25.3.

### What is the ROE and ROCE of Shilpa Medicare?

Return on equity was 9.4% in FY26 and return on capital employed was 11.4% in FY26 (consolidated figures).

### Is Shilpa Medicare a debt-free company?

No. Shilpa Medicare's debt-to-equity ratio was 0.25 in FY26, with total debt of ₹184 Cr.

### What were Shilpa Medicare's latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), Shilpa Medicare reported revenue of ₹466 Cr, +44.9% year on year, and net profit of ₹95 Cr, +99.3% year on year.

### How has Shilpa Medicare stock performed over the last year?

Shilpa Medicare's share price has risen 150.3% over the past year, +43.9% over three months and −17.5% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Shilpa Medicare?

As of 30 Jun 2026: promoters 40.13%, foreign institutions 11.38%, domestic institutions 8.05%, non-institutions 40.43%. 8.73% of promoter shares were pledged.

### Who are Shilpa Medicare's competitors?

The listed Pharma & Healthcare companies closest to Shilpa Medicare by market cap are Indraprastha, Cohance Lifesciences, Pfizer, Caplin Point Laboratories, Eris Lifesciences and Onesource Specialty Pharma.

### Is Shilpa Medicare a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Shilpa Medicare's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SHILPAMED against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.